It’s October 3rd. Today, we Skimm’d This:
Supervised injection sites for drug users just got a boost from a federal judge. We’ll explain why some cities think these facilities can reduce overdose deaths and why the feds are pushing back.
The US is dialing up its trade spat with the EU, and taking it out on some of Europe’s tastiest products.
2019’s been a bad year for tech IPOs. We’ll explain why going public isn’t what it used to be.
And one worldly bird is offering a new perspective on global warming.
theSkimm: A federal judge just gave a boost to supervised injection sites, saying a clinic in Philadelphia doesn’t violate drug laws. Activists say the ruling could mark a turning point in the fight to reduce drug overdoses. Meanwhile, Swiss cheese and French wine just got dragged into a US-EU trade spat that’s actually about … airplanes. We’ll connect the dots. Also on today’s show: we’ll break down the rough year for IPOs, and how one adventurous eagle is documenting glacial melt in the Alps.
Sign up for the Daily Skimm email newsletter.
Delivered to your inbox every morning and prepares you for your day in minutes.
Midterms. Are. Coming. theSkimm breaks down the biggest issues of 2018. Get informed and get to the polls #noexcuses
Hi, pass-through costs. Bye, market stability.
2019 was the year of the tech IPO, and not all have gone great.